There’s good news today for the more than 30,000 people receiving life-saving kidney transplants globally each year. Carlsbad, California-based Invitrogen aims to improve life after transplant with a new biomarker tool that addresses two chronic and life-threatening challenges: kidney rejection triggered by the graft and the cumulative cell and tissue damage caused by immunosuppressive drugs [...]
-
Pages
-
Categories
-
Archives